pfizer stock price: PFE price guide
pfizer stock price
What this article covers: a clear definition of the pfizer stock price, how quotes work, the company background that drives PFE value, valuation and trading metrics, historic events that moved the stock, recent news (including companion diagnostic data tied to Pfizer’s BREAKWATER trial), and practical guidance on tracking and trading. This article is intended for beginners and intermediate readers who want authoritative, sourceable information—not investment advice.
Company overview
The pfizer stock price reflects market participants’ view of Pfizer Inc., a large, multinational biopharmaceutical company historically known for prescription medicines, vaccines, oncology, rare disease and consumer healthcare collaborations. Founded in the 19th century, Pfizer’s commercial portfolio and R&D pipeline (including vaccines and oncology programs) materially affect the pfizer stock price because revenue, profit outlook and future growth depend on successful product launches, regulatory approvals and patent status.
Pfizer’s commercial drivers include established products, recurring vaccine revenues, and new therapies derived from clinical development. Changes in sales, margins, regulatory outcomes and large partnerships or legal settlements can cause meaningful movements in the pfizer stock price.
Ticker and market listing
- Ticker symbol: PFE
- Primary exchange: New York Stock Exchange (NYSE)
- Trading currency: U.S. dollar (USD)
- Regular trading hours: 09:30–16:00 ET (market open to close)
- Pre‑market and after‑hours trading: available on many platforms; quotes can differ from regular‑session last trade
- Availability: PFE is widely available on mainstream broker platforms and market data services, and can be tracked across finance portals and brokerage apps.
Note: when monitoring the pfizer stock price, confirm whether the feed is real‑time or delayed (often 15–20 minutes delayed on public portals) and whether the price shown is the last trade from regular hours or includes extended hours.
Current price and summary quote
A standard market quote for the pfizer stock price includes the following elements:
- Last trade: the most recent transaction price (regular session or extended hours if labeled)
- Bid / Ask: highest price buyers are willing to pay and lowest price sellers are asking (useful for assessing short‑term liquidity)
- Change and % change: absolute and percentage movement vs prior official close
- Volume: number of shares traded during the session (daily liquidity)
- After‑hours price: may be shown separately and can differ from the regular session closing price
Common sources for quotes: Yahoo Finance, Google Finance, CNBC, Morningstar, MarketWatch, Seeking Alpha, MarketBeat, and broker platforms (and direct company investor relations for official releases). For active trading and order execution, use a regulated broker or exchange; to track and trade digital assets or equities with advanced features, consider Bitget’s platform.
When evaluating the pfizer stock price on free portals, check the feed timestamp and whether the quote is real‑time or delayed.
Key price metrics and indicators
Investors and analysts monitor a standard set of metrics that summarize Pfizer’s valuation and market position. These are frequently shown alongside the pfizer stock price on quote pages.
- Market capitalization: price per share multiplied by shares outstanding, indicating the company’s equity value.
- Price‑to‑earnings (P/E) ratio: trailing and forward P/E help compare current price to earnings and near‑term estimates.
- Earnings per share (EPS): reported EPS and adjusted EPS (non‑GAAP) used in P/E calculations.
- Dividend and yield: Pfizer’s declared cash dividend per share and the resulting yield relative to the current pfizer stock price.
- Beta: measure of volatility relative to the overall market (S&P 500 baseline).
- 52‑week high / low: range that highlights recent extremes in the pfizer stock price.
- Average daily volume: liquidity gauge (30‑ or 90‑day averages are common).
- Analyst consensus & price targets: aggregated buy/hold/sell ratings and mean/median price targets from coverage.
- Short interest and days‑to‑cover: percent of float sold short and how many trading days it would take to cover — a sentiment and technical factor for the pfizer stock price.
These metrics are displayed on major market data pages and should be cross‑checked with official filings for fundamental numbers that feed valuation models.
Historical price performance
Tracking the pfizer stock price across multiple horizons provides perspective on long‑term growth, cyclical moves and event‑driven volatility. Common lookback periods include 1 day, 1 week, 1 month, 6 months, year‑to‑date, 1 year, 5 years and max (since IPO or earliest available data).
Important considerations for historical price analysis:
- Adjusted prices: use adjusted close prices that account for splits and dividend distributions when comparing long timeframes.
- Major inflection points: identify corporate events, macro shocks and sector rotations that explain large swings in the pfizer stock price.
Major historical events affecting price
- COVID‑19 vaccine era: the development, approval and global rollout of COVID vaccines caused a significant revenue surge and changed the pfizer stock price profile materially during 2020–2022. Subsequent normalization of pandemic‑related revenues contributed to price adjustments.
- Patent expirations and loss of exclusivity (LOE): when key product patents expire, generic competition can reduce revenues and pressure the pfizer stock price.
- Mergers & acquisitions: large M&A or divestitures shift forward growth expectations and capital structure, affecting the pfizer stock price.
- Regulatory rulings and approvals: FDA approvals, labeling decisions, and clinical readouts (positive or negative) often trigger sharp intraday moves in the pfizer stock price.
- Legal settlements and litigation: large settlements can create one‑time charges or contingent liabilities that affect the pfizer stock price.
52‑week range and records
The 52‑week high and low are routinely reported near the pfizer stock price on quote pages and help investors see recent volatility. Record highs or lows should be interpreted in context (e.g., pandemic revenue surge or post‑pandemic revenue normalization) and cross‑referenced with catalysts for those extremes.
Recent developments and drivers
Short‑term movements in the pfizer stock price are often driven by a handful of repeating themes:
- Quarterly earnings and management guidance
- Clinical trial readouts and regulatory filings
- Product launches and commercial execution
- Partnerships, licensing deals or collaborations
- Cost structure updates, workforce or strategic reorganizations
Below we highlight how these items commonly interact with the pfizer stock price and list typical sources to verify reported items.
Earnings, guidance and analyst reactions
Earnings reports and forward guidance are central to near‑term changes in the pfizer stock price. Typical dynamics include:
- Earnings beat (or miss) relative to consensus often produces an immediate gap in the pfizer stock price at market open or close, depending on when the release occurs.
- Upward or downward guidance adjustments from management influence forward P/E and analyst models, altering the pfizer stock price outlook.
- Analysts revise price targets and ratings on new information; aggregated sentiment (buy/hold/sell percentages) provides context for the magnitude of possible price moves.
Typical sources for near‑term market reaction and consensus: Seeking Alpha, MarketBeat, CNBC and platform research notes. Always check the company’s official earnings release and 8‑K for the most authoritative figures.
Pipeline, product and commercial updates
Clinical trial results, regulatory approvals, label expansions and product launches are high‑impact drivers. For example, as reported in market news:
- As of January 22, 2026, according to Benzinga, the U.S. Food and Drug Administration approved Guardant Health’s Guardant360 CDx as a companion diagnostic to identify patients with BRAF V600E‑mutant metastatic colorectal cancer who may benefit from treatment with Braftovi (encorafenib) in combination with cetuximab and chemotherapy. The accelerated approval for Braftovi was supported by data from Pfizer Inc.’s Phase 3 BREAKWATER trial, which showed significant improvements in objective response rate, progression‑free survival and overall survival compared with standard care.
This example demonstrates how Pfizer’s clinical program (the BREAKWATER trial) can influence downstream diagnostics, payer coverage and ultimately commercial uptake—factors that can feed into the pfizer stock price over time. The approval expanded access to less invasive genomic testing and helps clinicians identify eligible patients rapidly when tissue is unavailable or insufficient—an incremental commercial enabler for therapies tied to that biomarker.
Note: the Benzinga report also listed market‑level snapshots and short interest data for Pfizer at that time; check original reports and SEC filings for confirmed corporate data.
Dividends and total shareholder return
Pfizer has historically paid a regular cash dividend; the dividend yield is the annual dividend divided by the pfizer stock price. When evaluating total shareholder return (TSR), include both price appreciation and dividends reinvested.
Key dividend data to track:
- Most recent declared dividend per share
- Ex‑dividend date (the date by which you must own shares to receive the next dividend)
- Payment date and record date
- Dividend payout ratio (dividends divided by net income or adjusted EPS)
Dividends affect income‑seeking investors and are an input to dividend discount models when valuing the pfizer stock price on an income basis.
Trading characteristics and market microstructure
Understanding trading mechanics clarifies short‑term pfizer stock price behavior:
- Liquidity: measured by average daily volume and bid–ask spreads — high liquidity supports tighter spreads and easier execution.
- Intraday vs after‑hours: after‑hours quotes reflect trades outside regular hours; they can be more volatile and less liquid.
- Options activity and open interest: heavy options flow (puts/calls, large open interest) can be associated with directional bets or hedging that sometimes coincide with notable pfizer stock price moves.
- Volatility metrics: implied volatility from option prices vs historical volatility indicates how traders price future uncertainty in the pfizer stock price.
Valuation analysis
Valuation of the pfizer stock price commonly uses these approaches:
- Multiples: P/E (trailing and forward), price‑to‑sales (P/S), enterprise value multiples (EV/EBITDA) to compare Pfizer with peers.
- Discounted cash flow (DCF): project free cash flows and discount using a required rate of return to estimate a fair value that can be compared to the pfizer stock price.
- Dividend discount model (DDM): for dividend‑paying equities, the DDM values a stock by discounting expected dividends.
Analysts combine quantitative models with qualitative factors (pipeline outlook, regulatory risk, competitive dynamics) to derive 12‑month price targets and ratings that inform market expectations embedded in the pfizer stock price.
Ownership and share structure
Factors in the capital structure that impact the pfizer stock price include:
- Shares outstanding and free float: determine per‑share metrics and liquidity.
- Institutional ownership: major funds and institutional holders can influence price stability and voting outcomes.
- Insider ownership: management and director holdings align interests and can signal confidence levels.
- Share buybacks or issuance: can impact EPS and per‑share value, feeding into the pfizer stock price.
Market data providers and the company’s proxy and 10‑K/10‑Q filings list major holders and changes in ownership.
Risks and factors to monitor
Principal risks that may move the pfizer stock price:
- Clinical or regulatory failure for key pipeline programs
- Loss of patent exclusivity and generic competition (LOE)
- Pricing and reimbursement pressure from payers and governments
- Major litigation or settlements
- Competitive product launches (e.g., competing oncology agents)
- Macroeconomic or market‑wide selloffs that depress cyclical equities
Monitor SEC filings, official company statements and reliable market‑news outlets for developments that change these risk profiles.
How to track and trade Pfizer stock
Tracking:
- Real‑time quotes and charts: use market data portals (Yahoo Finance, Google Finance, CNBC, MarketWatch, Morningstar, Seeking Alpha, MarketBeat). Confirm real‑time vs delayed data.
- Official filings and press releases: Pfizer investor relations and SEC filings for authoritative financials and corporate actions.
- Analyst research and consensus: used to interpret valuations and price targets.
Trading (practical basics):
- Choose a regulated broker or trading venue. Bitget is recommended for users who want an exchange with trading tools and market access.
- Order types: market orders (immediate execution at current market price) vs limit orders (execute at a specified price or better).
- Trading hours: place trades during regular hours for best liquidity; extended hours trades may have wider spreads and lower volume.
- Risk controls: set position size, stop orders or alerts to manage exposure to changes in the pfizer stock price.
Important: this is educational information, not investment advice.
Related instruments and derivatives
Investor tools related to the pfizer stock price include:
- Options: puts and calls on PFE listed on standard options exchanges enable hedging or speculative positions tied to expected moves in the pfizer stock price.
- ETFs: sector and healthcare ETFs hold Pfizer exposure; changes in ETF flows can indirectly influence the pfizer stock price.
- ADRs / international listings: U.S. listing on NYSE is primary; some international instruments may provide indirect exposure.
Regulatory filings and investor relations
Authoritative sources for validating items that affect the pfizer stock price:
- Pfizer investor relations site for press releases, presentations, dividend declarations and event calendars
- SEC EDGAR filings (10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports) for certified financials and material events
- Company‑hosted earnings calls and transcripts for management commentary
Always reference primary filings when assessing changes that could influence the pfizer stock price.
See also
- Pfizer (company) profile and pipeline summaries
- List of largest pharmaceutical companies by market capitalization
- Healthcare sector and pharmaceutical ETFs that include Pfizer
- PFE historical price data pages on market data portals
References
- Pfizer investor relations and SEC filings (10‑K, 10‑Q, 8‑K) — for official financial data and corporate events.
- Market data providers: Yahoo Finance, Google Finance, CNBC, Morningstar, MarketWatch, Seeking Alpha, MarketBeat — for quotes, analyst consensus and market commentary.
- Benzinga report (as of January 22, 2026) summarizing recent FDA approval for Guardant360 CDx and referencing Pfizer’s BREAKWATER trial data and contemporaneous market snapshots.
Sources cited above are typical reference points for prices, metrics and news that influence the pfizer stock price. For every material corporate claim, consult the original company filing or press release.
External links and official resources
- Pfizer investor relations (official)
- SEC EDGAR filings (searchable repository)
- Major finance portals: Yahoo Finance, Google Finance, CNBC, Morningstar, MarketWatch
If you want to monitor the pfizer stock price in real time and access trading tools, consider using Bitget’s platform for charts, order types and market data. Explore Bitget’s features to set alerts and manage positions efficiently.
This article is for informational and educational purposes only and is not investment advice. Verify all data with primary sources before making financial decisions.
